The World Health Organization (WHO) says it does not expect widespread immunization against the corona virus until mid-2021, as research reveals that early results from a Russian vaccine are promoting it.

The virus, which has killed more than 870,000 people worldwide, continues to spread, according to Italy’s former prime minister Silvio Berlusconi is currently in hospital as the latest person to test positive for Kovid-19.

Another note on the potential for the vaccine was given by David Nabaro, the World Health Organization’s special envoy for Kovid-19. He told Times Radio in the UK that it may be too late until 2022 to prepare an antidote.

Governments are expected to announce a vaccine soon against the virus that has infected more than 26 million people worldwide, claimed millions of lives and devastated the global economy.

The World Health Organization (WHO) has welcomed the fact that tens of thousands of vaccine candidates have entered the final stages of testing.

“Based on realistic timelines, we do not expect extensive immunizations until the middle of next year,” said spokeswoman Margaret Harris.

Health Minister Stephen Donnelly discussed the purchase of Kovid-19 vaccines in a virtual meeting with the European Union.

In a statement, he said: “Ireland fully supports the goal of achieving a broad portfolio of candidate vaccines that include a variety of technical approaches, providing an excellent opportunity to secure a safe and effective vaccine against Kovid-19.”

The head of the World Health Organization, Tedros Adanom Gebrias, said the agency would not approve the vaccine unless it was effective and safe.

He called on countries around the world to join forces to fight the corona virus, saying “vaccine nationalism” would slow down the response to the epidemic.

The WHO Director-General said that 78 high-income countries have now joined the “Kovacs” global vaccine allocation program and have reached a total of 170 countries.

Russia A vaccine has already been approved According to research published in the journal Lancet Medical, patients involved in early testing developed antibodies “without serious adverse events.”

But scientists warned that the experiments were too small and that only 76 people participated.

The White House has asked U.S. states to make the vaccine available by November 3. The administration of President Donald Trump is in a hurry to distribute the vaccine before the November 3 election.

Under normal procedures, test administrators may have to wait months or years to verify that vaccine candidates are safe and effective.

As the epidemic continues, there has been a great deal of pressure to release a vaccine quickly.